drugset / Trial / NCT06570655
The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects
Phase 1
Completed
12 enrolled
Wanbangde Pharmaceutical Group Co., LTD
Zhejiang Xiaoshan hospital · collab
NaSequentialOpen-labelTreatment
Summary
The study used a single-center, open, sequential single-dose design. To evaluate the pharmacokinetics and dose-exposure relationship of huperzine A injection
Timeline
- Start
- 2024-05-16
- Primary completion
- 2024-06-20
- Completion
- 2024-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 0.1 mg | Intramuscular |
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 0.2 mg | Intramuscular |
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 0.4 mg | Intramuscular |
Indications
No indication recorded.